|
⚲
|
| Keyboard |
| Mahatme Ujwala
✚
|
|
|---|---|
| CIK # | 0001823894 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001823894] | |
| 4 | [0001823894] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Summit Therapeutics Inc | |
| Mahatme Ujwala |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2024-01-02 | Grant | 52,575 | $1.32 | 69,399 |
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2024-01-02 | Grant | 35,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2023-01-03 | Grant | 40,500 | $1.67 | 67,635 |
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2023-01-03 | Grant | 35,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2022-01-03 | Grant | 25,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2022-01-03 | Grant | 47,872 | $1.13 | 54,095 |
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2021-02-19 | Grant | 25,000 |